The announcement follows the CDC’s endorsement of Pfizer boosters for millions of older or otherwise vulnerable Americans.

The CDC advisers said boosters should be offered to people 65 and older, nursing home residents and those ages 50 to 64 who have risky underlying health problems.

117 Penn State University students were recently temporarily suspended for missing COVID-19 tests.

Advisers to the Centers for Disease Control and Prevention have recommended a third dose of Pfizer's COVID-19 vaccine for people 65 and older, as well as others at a high risk

Many K-12 school districts are tapping federal funds to pay for regular surveillance testing of students. It's an effective pandemic tactic, when used alongside mask-wearing.

The U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to seniors and others at high risk from the virus.

So far, seven schools in New Jersey have reimplemented virtual instruction due to COVID outbreaks, and three of them remain remote.

The FDA itself still has to decide whether it agrees with its advisers’ recommendation and will authorize Pfizer boosters.

Philadelphia health officials have lowered the thresholds for when school buildings close because of positive COVID-19 cases. Here’s what you need to know.

The increasingly lethal turn has filled hospitals, complicated the start of the school year, delayed the return to offices and demoralized health care workers.

The pledge will come at the start of a virtual summit aimed at boosting commitments from other nations and the private sector.

A vaccine for children ages 5-11 could be ready next month. Experts say it will be important to roll it out quickly — especially in the Philly region.

Pennsylvania health officials on Tuesday ordered COVID-19 vaccine providers to spin up operations ahead of an expected federal booster shot approval.

The COVID-19 crisis is by any measure a colossal tragedy in its own right, especially given the incredible advances in scientific knowledge since 1918.

J&J shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.